Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients

2011 ◽  
Vol 69 (4) ◽  
pp. 957-964 ◽  
Author(s):  
Chigusa Morizane ◽  
Takuji Okusaka ◽  
Hideki Ueno ◽  
Shunsuke Kondo ◽  
Masafumi Ikeda ◽  
...  
2005 ◽  
Vol 35 (12) ◽  
pp. 733-738 ◽  
Author(s):  
Junji Furuse ◽  
Hiroshi Ishii ◽  
Takuji Okusaka ◽  
Michitaka Nagase ◽  
Kohei Nakachi ◽  
...  

Pancreas ◽  
2005 ◽  
Vol 31 (4) ◽  
pp. 431-432
Author(s):  
T Aimoto ◽  
E Uchida ◽  
Y Nakamura ◽  
A Katsuno ◽  
K Cho ◽  
...  

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 4120-4120
Author(s):  
B. Kobrossy ◽  
B. F. El-Rayes ◽  
A. F. Shields ◽  
U. Vaishampayan ◽  
L. Heilbrun ◽  
...  

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 4120-4120
Author(s):  
B. Kobrossy ◽  
B. F. El-Rayes ◽  
A. F. Shields ◽  
U. Vaishampayan ◽  
L. Heilbrun ◽  
...  

2006 ◽  
Vol 94 (12) ◽  
pp. 1797-1802 ◽  
Author(s):  
A López-Pousa ◽  
R Losa ◽  
J Martín ◽  
J Maurel ◽  
J Fra ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document